These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 16927414

  • 1. Expression and activity of mTOR and its substrates in different cell cycle phases and in oral squamous cell carcinomas of different malignant grade.
    Liu Y, Hidayat S, Su WH, Deng X, Yu DH, Yu BZ.
    Cell Biochem Funct; 2007; 25(1):45-53. PubMed ID: 16927414
    [Abstract] [Full Text] [Related]

  • 2. [The expression of mTOR and its substrates in oral squamous cell carcinoma].
    Liu Y, Yang ML, Zhang Y, Yu BZ.
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Aug; 22(4):331-3. PubMed ID: 15379322
    [Abstract] [Full Text] [Related]

  • 3. [The expression of mammalian target of rapamycin and its substrates in autogenous vein graft in rats].
    Hu XH, Zhang Q, Yang J, Liu CW, Zhang ZS, Wang J, Liu GF.
    Zhonghua Wai Ke Za Zhi; 2006 Aug 01; 44(15):1053-7. PubMed ID: 17074246
    [Abstract] [Full Text] [Related]

  • 4. Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy.
    García-Maceira P, Mateo J.
    Oncogene; 2009 Jan 22; 28(3):313-24. PubMed ID: 18978810
    [Abstract] [Full Text] [Related]

  • 5. An activated mTOR/p70S6K signaling pathway in esophageal squamous cell carcinoma cell lines and inhibition of the pathway by rapamycin and siRNA against mTOR.
    Hou G, Xue L, Lu Z, Fan T, Tian F, Xue Y.
    Cancer Lett; 2007 Aug 18; 253(2):236-48. PubMed ID: 17360108
    [Abstract] [Full Text] [Related]

  • 6. Morphoproteomic profile of mTOR, Ras/Raf kinase/ERK, and NF-kappaB pathways in human gastric adenocarcinoma.
    Feng W, Brown RE, Trung CD, Li W, Wang L, Khoury T, Alrawi S, Yao J, Xia K, Tan D.
    Ann Clin Lab Sci; 2008 Aug 18; 38(3):195-209. PubMed ID: 18715846
    [Abstract] [Full Text] [Related]

  • 7. Morphoproteomic and pharmacoproteomic rationale for mTOR effectors as therapeutic targets in head and neck squamous cell carcinoma.
    Brown RE, Zhang PL, Lun M, Zhu S, Pellitteri PK, Riefkohl W, Law A, Wood GC, Kennedy TL.
    Ann Clin Lab Sci; 2006 Aug 18; 36(3):273-82. PubMed ID: 16951268
    [Abstract] [Full Text] [Related]

  • 8. mTOR signaling pathway is a target for the treatment of colorectal cancer.
    Zhang YJ, Dai Q, Sun DF, Xiong H, Tian XQ, Gao FH, Xu MH, Chen GQ, Han ZG, Fang JY.
    Ann Surg Oncol; 2009 Sep 18; 16(9):2617-28. PubMed ID: 19517193
    [Abstract] [Full Text] [Related]

  • 9. Morphoproteomic and molecular concomitants of an overexpressed and activated mTOR pathway in renal cell carcinomas.
    Lin F, Zhang PL, Yang XJ, Prichard JW, Lun M, Brown RE.
    Ann Clin Lab Sci; 2006 Sep 18; 36(3):283-93. PubMed ID: 16951269
    [Abstract] [Full Text] [Related]

  • 10. Acetaldehyde promotes rapamycin-dependent activation of p70(S6K) and glucose uptake despite inhibition of Akt and mTOR in dopaminergic SH-SY5Y human neuroblastoma cells.
    Fang CX, Yang X, Sreejayan N, Ren J.
    Exp Neurol; 2007 Jan 18; 203(1):196-204. PubMed ID: 16962100
    [Abstract] [Full Text] [Related]

  • 11. The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation.
    Follo MY, Mongiorgi S, Bosi C, Cappellini A, Finelli C, Chiarini F, Papa V, Libra M, Martinelli G, Cocco L, Martelli AM.
    Cancer Res; 2007 May 01; 67(9):4287-94. PubMed ID: 17483341
    [Abstract] [Full Text] [Related]

  • 12. Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer.
    Castellvi J, Garcia A, Rojo F, Ruiz-Marcellan C, Gil A, Baselga J, Ramon y Cajal S.
    Cancer; 2006 Oct 15; 107(8):1801-11. PubMed ID: 16983702
    [Abstract] [Full Text] [Related]

  • 13. Critical and diverse involvement of Akt/mammalian target of rapamycin signaling in human lung carcinomas.
    Dobashi Y, Suzuki S, Matsubara H, Kimura M, Endo S, Ooi A.
    Cancer; 2009 Jan 01; 115(1):107-18. PubMed ID: 19090006
    [Abstract] [Full Text] [Related]

  • 14. [Effects of mTOR siRNA on mTOR/p70S6K signaling pathway in esophageal squamous cell carcinoma cells and the growth of transplanted tumor in nude mice].
    Liu MY, Hou GQ, Zhang Y, Bei WJ, Yan AH.
    Zhonghua Zhong Liu Za Zhi; 2011 May 01; 33(5):334-9. PubMed ID: 21875460
    [Abstract] [Full Text] [Related]

  • 15. Simultaneous activation of impaired autophagy and the mammalian target of rapamycin pathway in oral squamous cell carcinoma.
    Yin X, Hu L, Feng X, Wang H, Zhang C, Wang H, Wang S.
    J Oral Pathol Med; 2019 Sep 01; 48(8):705-711. PubMed ID: 31132188
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of the mammalian target of rapamycin pathway and the effect of rapamycin on target expression and cellular proliferation in osteosarcoma cells from dogs.
    Gordon IK, Ye F, Kent MS.
    Am J Vet Res; 2008 Aug 01; 69(8):1079-84. PubMed ID: 18672974
    [Abstract] [Full Text] [Related]

  • 17. Loss of 14-3-3 sigma protein expression and presence of human papillomavirus type 16 E6 in oral squamous cell carcinoma.
    Bhawal UK, Sugiyama M, Nomura Y, Kuniyasu H, Tsukinoki K.
    Arch Otolaryngol Head Neck Surg; 2008 Oct 01; 134(10):1055-9. PubMed ID: 18936350
    [Abstract] [Full Text] [Related]

  • 18. The novel orally bioavailable inhibitor of phosphoinositol-3-kinase and mammalian target of rapamycin, NVP-BEZ235, inhibits growth and proliferation in multiple myeloma.
    Baumann P, Mandl-Weber S, Oduncu F, Schmidmaier R.
    Exp Cell Res; 2009 Feb 01; 315(3):485-97. PubMed ID: 19071109
    [Abstract] [Full Text] [Related]

  • 19. Expression of mTOR and downstream signalling components in the JEG-3 and BeWo human placental choriocarcinoma cell lines.
    Mparmpakas D, Zachariades E, Foster H, Kara A, Harvey A, Goumenou A, Karteris E.
    Int J Mol Med; 2010 Jan 01; 25(1):65-9. PubMed ID: 19956903
    [Abstract] [Full Text] [Related]

  • 20. Loss of expression of TGF-beta1, TbetaRI, and TbetaRII correlates with differentiation in human oral squamous cell carcinomas.
    Mincione G, Di Marcantonio MC, Artese L, Vianale G, Piccirelli A, Piccirilli M, Perrotti V, Rubini C, Piattelli A, Muraro R.
    Int J Oncol; 2008 Feb 01; 32(2):323-31. PubMed ID: 18202754
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.